Yahoo India Web Search

Sign In

Search results

  1. www.timesnownews.com › health › what-is-non-hodgkinWhat is Non-Hodgkin lymphoma cancer that Barclays bank CEO ...

    Nov 28, 2022 · That is why Barclays has stated through a spokesperson that their 56-year-old Chief Executive Officer (CEO) CS Venkatakrishnan would undergo treatment for several months for non-Hodgkin lymphoma, a type of cancer, adding that since the condition is treatable, he would keep working when possible.

    • Kirti Pandey

  2. www.ft.com › content › 425a3c92-31e6-4fcc-a080-7cc3Barclays chief: the life lessons I have discovered during ...

    Feb 4, 2023 · CS Venkatakrishnan gives his personal account of leading the bank while undergoing care for non-Hodgkin lymphoma. CS Venkatakrishnan, Barclays chief executive, says that his experience has...

  3. news.sky.com › story › barclays-boss-venkat-toBarclays boss Venkat to receive cancer treatment in New York

    Nov 28, 2022 · Coimbatore Sundararajan Venkatakrishnan, known as Venkat within the bank, is to undergo treatment for non-Hodgkin lymphoma in New York. That was expected to last between 12 and 16 weeks, during which time he will work at home for some periods.

  4. www.cnn.com › 2022/11/28 › businessBarclays CEO says he has cancer but will continue to run the ...

    Nov 28, 2022 · C.S. Venkatakrishnan, who is known as Venkat at the bank, said in a note to colleagues that he will begin undergoing treatment for Non-Hodgkin lymphoma at Memorial Sloan Kettering Cancer...

  5. en.wikipedia.org › wiki › CC. S. Venkatakrishnan - Wikipedia

    Venkat is based in New York City. [4] He was diagnosed with non-Hodgkin lymphoma in November 2022, and continued to work while being treated. [10] He is in remission after completing the treatment in March 2023. [11] Venkat is married and has three children. [12]

  6. www.reuters.com › world › ukBarclays CEO Venkat to undergo cancer treatment, prognosis ...

    Nov 28, 2022 · LONDON, Nov 28 (Reuters) - Barclays PLC (BARC.L) said on Monday that Chief Executive C.S. Venkatakrishnan would undergo treatment for non-Hodgkin lymphoma, a type of cancer, adding that...

  7. People also ask

  8. www.bankingdive.com › news › barclays-ceo-venkatBarclays CEO Venkat diagnosed with cancer | Banking Dive

    Nov 28, 2022 · Barclays CEO C.S. Venkatakrishnan has been diagnosed with non-Hodgkin lymphoma and will undergo treatment for 12 to 16 weeks at New York City’s Memorial Sloan Kettering Cancer Center, he wrote in a letter to the bank that was included in a Securities and Exchange Commission (SEC) filing Monday.